BMO’s Seigerman on Pfizer-Metsera deal: Bullish as we’ve waited on Pfizer’s foray into obesity
Evan Seigerman, BMO Capital Markets head of healthcare research, joins 'The Exchange' to discuss Pfizer's obesity drug prospects, competitors and ...
Tuesday, March 3, 2026
Tag: Pfizers
Breaking down Pfizer’s first quarter earnings results, tariff impacts
Pfizer's (PFE) first quarter earnings were mixed, with sales coming in narrowly below Wall Street expectations. The pharmaceutical company has ...
- Trending
- Comments
- Latest
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.